Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
Autor: | Saad, Fred, Fizazi, Karim, Jinga, Viorel, Efstathiou, Eleni, Fong, Peter C, Hart, Lowell L, Jones, Robert, McDermott, Raymond, Wirth, Manfred, Suzuki, Kazuhiro, MacLean, David B, Wang, Ling, Akaza, Hideyuki, Nelson, Joel, Scher, Howard I, Dreicer, Robert, Webb, Iain J, de Wit, Ronald |
---|---|
Zdroj: | In The Lancet Oncology March 2015 16(3):338-348 |
Databáze: | ScienceDirect |
Externí odkaz: |